Halozyme Therapeutics, Inc. (HALO)
USD 59.65
(-3.67%)
USD 59.65
(-3.67%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 1.38 Billion USD | 8.57% |
| 2022 | 1.27 Billion USD | 67.81% |
| 2021 | 757.95 Million USD | 203.76% |
| 2020 | 249.52 Million USD | -11.64% |
| 2019 | 282.4 Million USD | 312.61% |
| 2018 | 68.44 Million USD | 103.64% |
| 2017 | 33.61 Million USD | -77.57% |
| 2016 | 149.85 Million USD | 2191.04% |
| 2015 | 6.54 Million USD | 156.74% |
| 2014 | -11.52 Million USD | -151.43% |
| 2013 | 22.41 Million USD | 132.58% |
| 2012 | -68.78 Million USD | -30.22% |
| 2011 | -52.82 Million USD | 36.55% |
| 2010 | -83.25 Million USD | -23.41% |
| 2009 | -67.46 Million USD | -5.88% |
| 2008 | -63.71 Million USD | 34.77% |
| 2007 | -97.67 Million USD | -121.05% |
| 2006 | -44.18 Million USD | -130.97% |
| 2005 | -19.13 Million USD | -19.52% |
| 2004 | -16 Million USD | -33588.39% |
| 2003 | -47.51 Thousand USD | -115.7% |
| 2002 | 302.75 Thousand USD | 1258.77% |
| 2001 | -26.12 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 1.34 Billion USD | -1.66% |
| 2024 Q1 | 1.36 Billion USD | -0.93% |
| 2024 Q3 | 1.34 Billion USD | 0.34% |
| 2023 Q2 | 1.27 Billion USD | -8.81% |
| 2023 Q1 | 1.39 Billion USD | 9.91% |
| 2023 Q4 | 1.38 Billion USD | 12.87% |
| 2023 FY | 1.38 Billion USD | 8.57% |
| 2023 Q3 | 1.22 Billion USD | -4.03% |
| 2022 Q1 | 759.81 Million USD | 0.24% |
| 2022 Q3 | 1.35 Billion USD | 17.49% |
| 2022 FY | 1.27 Billion USD | 67.81% |
| 2022 Q2 | 1.15 Billion USD | 52.04% |
| 2022 Q4 | 1.27 Billion USD | -6.29% |
| 2021 Q2 | 427.77 Million USD | 14.28% |
| 2021 Q1 | 374.32 Million USD | 50.01% |
| 2021 Q3 | 384.02 Million USD | -10.23% |
| 2021 Q4 | 757.95 Million USD | 97.37% |
| 2021 FY | 757.95 Million USD | 203.76% |
| 2020 Q3 | 327.89 Million USD | 27.85% |
| 2020 Q4 | 249.52 Million USD | -23.9% |
| 2020 FY | 249.52 Million USD | -11.64% |
| 2020 Q1 | 284.61 Million USD | 0.78% |
| 2020 Q2 | 256.47 Million USD | -9.89% |
| 2019 FY | 282.4 Million USD | 312.61% |
| 2019 Q1 | 44.81 Million USD | -34.53% |
| 2019 Q2 | 17.92 Million USD | -60.01% |
| 2019 Q3 | 4.64 Million USD | -74.09% |
| 2019 Q4 | 282.4 Million USD | 5982.45% |
| 2018 FY | 68.44 Million USD | 103.64% |
| 2018 Q3 | 91.44 Million USD | -17.52% |
| 2018 Q4 | 68.44 Million USD | -25.15% |
| 2018 Q2 | 110.87 Million USD | 27.23% |
| 2018 Q1 | 87.14 Million USD | 159.27% |
| 2017 Q4 | 33.61 Million USD | -20.83% |
| 2017 Q2 | 96.28 Million USD | -42.97% |
| 2017 Q1 | 168.84 Million USD | 12.67% |
| 2017 Q3 | 42.45 Million USD | -55.91% |
| 2017 FY | 33.61 Million USD | -77.57% |
| 2016 Q4 | 149.85 Million USD | -0.75% |
| 2016 FY | 149.85 Million USD | 2191.04% |
| 2016 Q2 | 146.9 Million USD | 15.74% |
| 2016 Q3 | 150.99 Million USD | 2.78% |
| 2016 Q1 | 126.92 Million USD | 1840.44% |
| 2015 Q2 | -18.01 Million USD | -431.89% |
| 2015 FY | 6.54 Million USD | 156.74% |
| 2015 Q1 | 5.42 Million USD | 147.08% |
| 2015 Q4 | 6.54 Million USD | 130.11% |
| 2015 Q3 | -21.72 Million USD | -20.57% |
| 2014 Q4 | -11.52 Million USD | -433.02% |
| 2014 Q3 | 3.46 Million USD | 154.79% |
| 2014 Q2 | -6.31 Million USD | 76.4% |
| 2014 Q1 | -26.77 Million USD | -219.46% |
| 2014 FY | -11.52 Million USD | -151.43% |
| 2013 Q4 | 22.41 Million USD | 51.35% |
| 2013 Q3 | 14.8 Million USD | 280.61% |
| 2013 Q2 | 3.89 Million USD | 149.36% |
| 2013 Q1 | -7.88 Million USD | 88.54% |
| 2013 FY | 22.41 Million USD | 132.58% |
| 2012 Q2 | -102.04 Million USD | 12.49% |
| 2012 FY | -68.78 Million USD | -30.22% |
| 2012 Q3 | -87.61 Million USD | 14.14% |
| 2012 Q4 | -68.78 Million USD | 21.49% |
| 2012 Q1 | -116.6 Million USD | -120.74% |
| 2011 Q1 | -73.82 Million USD | 11.32% |
| 2011 Q4 | -52.82 Million USD | 20.36% |
| 2011 FY | -52.82 Million USD | 36.55% |
| 2011 Q3 | -66.32 Million USD | 16.16% |
| 2011 Q2 | -79.11 Million USD | -7.16% |
| 2010 Q4 | -83.25 Million USD | 7.33% |
| 2010 Q2 | -41.31 Million USD | 25.13% |
| 2010 Q3 | -89.84 Million USD | -117.47% |
| 2010 Q1 | -55.17 Million USD | 18.21% |
| 2010 FY | -83.25 Million USD | -23.41% |
| 2009 Q3 | -77.63 Million USD | 13.0% |
| 2009 FY | -67.46 Million USD | -5.88% |
| 2009 Q4 | -67.46 Million USD | 13.1% |
| 2009 Q2 | -89.24 Million USD | -43.79% |
| 2009 Q1 | -62.06 Million USD | 2.59% |
| 2008 Q4 | -63.71 Million USD | 12.11% |
| 2008 FY | -63.71 Million USD | 34.77% |
| 2008 Q1 | -92.55 Million USD | 5.24% |
| 2008 Q2 | -82.41 Million USD | 10.96% |
| 2008 Q3 | -72.49 Million USD | 12.03% |
| 2007 Q1 | -70.97 Million USD | -60.61% |
| 2007 FY | -97.67 Million USD | -121.05% |
| 2007 Q4 | -97.67 Million USD | 7.07% |
| 2007 Q3 | -105.11 Million USD | -4.49% |
| 2007 Q2 | -100.59 Million USD | -41.74% |
| 2006 Q1 | -17.57 Million USD | 8.16% |
| 2006 Q3 | -16.1 Million USD | -6.63% |
| 2006 Q4 | -44.18 Million USD | -174.45% |
| 2006 FY | -44.18 Million USD | -130.97% |
| 2006 Q2 | -15.09 Million USD | 14.06% |
| 2005 Q1 | -13.13 Million USD | 17.98% |
| 2005 Q4 | -19.13 Million USD | -188.33% |
| 2005 FY | -19.13 Million USD | -19.52% |
| 2005 Q3 | -6.63 Million USD | 34.04% |
| 2005 Q2 | -10.06 Million USD | 23.38% |
| 2004 Q2 | -5.93 Million USD | -104.62% |
| 2004 Q4 | -16 Million USD | -359.95% |
| 2004 Q3 | -3.48 Million USD | 41.41% |
| 2004 Q1 | 128.47 Million USD | 270481.52% |
| 2004 FY | -16 Million USD | -33588.39% |
| 2003 Q3 | -62.64 Thousand USD | 9.55% |
| 2003 Q2 | -69.25 Thousand USD | 5.27% |
| 2003 Q4 | -47.51 Thousand USD | 24.15% |
| 2003 Q1 | -73.11 Thousand USD | 24.82% |
| 2003 FY | -47.51 Thousand USD | -115.7% |
| 2002 Q3 | -111.79 Thousand USD | 8.58% |
| 2002 Q4 | -97.24 Thousand USD | 13.01% |
| 2002 Q1 | -13.5 Thousand USD | 0.0% |
| 2002 Q2 | -122.28 Thousand USD | -805.67% |
| 2002 FY | 302.75 Thousand USD | 1258.77% |
| 2001 FY | -26.12 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | 2568.498% |
| Alkermes plc | -166.73 Million USD | 928.167% |
| Agenus Inc. | 274.13 Million USD | -403.72% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 26.154% |
| Aptorum Group Limited | 1.35 Million USD | -101656.167% |
| Ardelyx, Inc. | 34.51 Million USD | -3901.153% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | -32163.505% |
| Bicycle Therapeutics plc | -481.46 Million USD | 386.806% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | -3718.483% |
| ChromaDex Corporation | -24.04 Million USD | 5842.174% |
| Chimerix, Inc. | -25.51 Million USD | 5511.6% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | -19717.206% |
| Caribou Biosciences, Inc. | -23.67 Million USD | 5932.149% |
| CRISPR Therapeutics AG | -150.84 Million USD | 1015.428% |
| Precision BioSciences, Inc. | -85.41 Million USD | 1716.764% |
| Dyadic International, Inc. | -6.37 Million USD | 21750.307% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | 8766.78% |
| Fortress Biotech, Inc. | 7.66 Million USD | -17915.369% |
| Lantern Pharma Inc. | -21.7 Million USD | 6462.532% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | 1349.245% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | 16263.52% |
| Incyte Corporation | -3.17 Billion USD | 143.491% |
| IO Biotech, Inc. | -140.69 Million USD | 1081.441% |
| Jaguar Health, Inc. | 29.39 Million USD | -4598.302% |
| Novavax, Inc. | -298.29 Million USD | 562.925% |
| Janux Therapeutics, Inc. | 5.33 Million USD | -25773.674% |
| Opthea Limited | 28.15 Million USD | -4804.131% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | 8324.897% |
| ContextLogic Inc. | -232 Million USD | 695.206% |
| MiMedx Group, Inc. | -33.9 Million USD | 4173.266% |
| Pyxis Oncology, Inc. | 10.19 Million USD | -13444.659% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | 59696.975% |
| NextCure, Inc. | -6.47 Million USD | 21419.716% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | 2834.358% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | 21747.249% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | -11252.854% |
| Vaxcyte, Inc. | -368.22 Million USD | 475.007% |
| PDS Biotechnology Corporation | -32.7 Million USD | 4321.719% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | -7892.117% |
| Pharming Group N.V. | 109.8 Million USD | -1157.584% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | 8037.905% |
| Avidity Biosciences, Inc. | -175.23 Million USD | 888.037% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 7556.203% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | 7556.203% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | 19548.986% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | 23664.471% |
| Acelyrin, Inc. | -216.9 Million USD | 736.634% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | 24713.41% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | 80197.332% |
| Summit Therapeutics Inc. | 34.67 Million USD | -3882.459% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | 20398.074% |
| Senti Biosciences, Inc. | 1.74 Million USD | -79260.805% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | 848.01% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | 1882.905% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | 22879.248% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | -1383975.214% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | -219785.032% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | 1279.774% |
| Wave Life Sciences Ltd. | -168.23 Million USD | 920.813% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | -1145.493% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | 18279.015% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | 1169.503% |
| Psyence Biomedical Ltd. | 6.89 Million USD | -19928.405% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 669.756% |
| Immix Biopharma, Inc. | -17.5 Million USD | 7986.319% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 536.017% |
| MEI Pharma, Inc. | -3.7 Million USD | 37370.661% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | -10937.311% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | -753.754% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | -4868.438% |
| Fortress Biotech, Inc. | 7.66 Million USD | -17915.369% |
| Precigen, Inc. | -481 Thousand USD | 287184.823% |
| Clearside Biomedical, Inc. | 14.08 Million USD | -9706.676% |
| AlloVir, Inc. | -62.69 Million USD | 2302.638% |
| C4 Therapeutics, Inc. | -55.61 Million USD | 2582.968% |
| Fate Therapeutics, Inc. | 61.66 Million USD | -2139.286% |
| ImmuCell Corporation | 10.99 Million USD | -12464.216% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | 995.825% |
| Onconetix, Inc. | 5.33 Million USD | -25800.672% |
| PureTech Health plc | -167.19 Million USD | 925.899% |
| VYNE Therapeutics Inc. | -30.46 Million USD | 4633.414% |
| Elevation Oncology, Inc. | -19.11 Million USD | 7322.921% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | 28229.517% |
| Seer, Inc. | -4.24 Million USD | 32667.877% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | 5844.802% |
| Innoviva, Inc. | 255.56 Million USD | -440.328% |
| Aadi Bioscience, Inc. | -55.86 Million USD | 2571.857% |
| ESSA Pharma Inc. | -33.62 Million USD | 4207.118% |
| GlycoMimetics, Inc. | -40.98 Million USD | 3469.275% |
| GT Biopharma, Inc. | -1.02 Million USD | 135347.6% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | 2137.204% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | -2154.237% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | 1129.899% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | 10065.921% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | 4882.758% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | 1833107.672% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | 4574.363% |
| Aptose Biosciences Inc. | -8.19 Million USD | 16950.544% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | 44231.354% |
| Soligenix, Inc. | -4.95 Million USD | 27987.528% |
| Century Therapeutics, Inc. | 847 Thousand USD | -162931.641% |
| Kura Oncology, Inc. | -20.11 Million USD | 6963.893% |
| TScan Therapeutics, Inc. | -40.92 Million USD | 3474.085% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | 16542.939% |
| Ocean Biomedical, Inc. | 1.82 Million USD | -75701.822% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | 43292.931% |
| Autolus Therapeutics plc | -186.59 Million USD | 840.024% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | 2900.742% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 600.692% |
| Eterna Therapeutics Inc. | 34.26 Million USD | -3929.643% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | -740.114% |
| GRI Bio, Inc. | -1.79 Million USD | 77072.018% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | 15472.046% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | 4252.142% |
| IGM Biosciences, Inc. | -72.6 Million USD | 2001.879% |
| INmune Bio, Inc. | -25.41 Million USD | 5534.174% |
| Heron Therapeutics, Inc. | 150.95 Million USD | -814.786% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2825.829% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 8598.039% |
| Entero Therapeutics, Inc. | -2.88 Million USD | 47965.283% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | -3532.456% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | 3452.866% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | -4230.808% |
| Coherus BioSciences, Inc. | 377.95 Million USD | -265.359% |
| Verastem, Inc. | -37.27 Million USD | 3804.271% |
| Abeona Therapeutics Inc. | -9.07 Million USD | 15319.641% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | 2762.601% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | 9223.74% |
| Histogen Inc. | -7.48 Million USD | 18543.676% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | 6490.936% |
| Surrozen, Inc. | -32.66 Million USD | 4327.523% |
| Organovo Holdings, Inc. | -1.5 Million USD | 91730.922% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 32950.766% |
| Ovid Therapeutics Inc. | 18.96 Million USD | -7183.032% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | -52685.856% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | -33126.131% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | 16575.997% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | 3278.67% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | 9573.083% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 535.898% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | 191341.448% |
| Apollomics, Inc. | -27.39 Million USD | 5140.621% |
| Amarin Corporation plc | -191.04 Million USD | 822.821% |
| Mesoblast Limited | 55.96 Million USD | -2367.484% |
| Turnstone Biologics Corp. | -14.58 Million USD | 9568.445% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | 5559.742% |
| Synaptogenix, Inc. | -28.66 Million USD | 4917.885% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | 147629.701% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | -2733.617% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 160278.125% |
| Monopar Therapeutics Inc. | -7.26 Million USD | 19104.443% |
| Exelixis, Inc. | -73.05 Million USD | 1990.319% |
| Better Therapeutics, Inc. | -860 Thousand USD | 160667.209% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | 5850.543% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 672.098% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -187502.47% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | 18664.842% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | -110017.863% |
| Gritstone bio, Inc. | 39.49 Million USD | -3396.779% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1741.928% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | 52562.179% |
| Avid Bioservices, Inc. | 169.72 Million USD | -713.583% |
| Insmed Incorporated | 721.62 Million USD | -91.358% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | 15205.576% |
| MediWound Ltd. | -5.32 Million USD | 26046.599% |
| OmniAb, Inc. | 9.2 Million USD | -14904.651% |
| Alector, Inc. | -35.63 Million USD | 3974.844% |
| Seres Therapeutics, Inc. | 85.97 Million USD | -1506.214% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | 28121.063% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | -10330.38% |
| Zai Lab Limited | -775 Million USD | 278.178% |
| Revance Therapeutics, Inc. | 340.55 Million USD | -305.479% |
| Aura Biosciences, Inc. | -21.52 Million USD | 6515.229% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | 1774.197% |
| Immunic, Inc. | -45.34 Million USD | 3145.607% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | 814.685% |
| Veracyte, Inc. | -203.82 Million USD | 777.485% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | -116.339% |
| FibroGen, Inc. | 56.76 Million USD | -2332.537% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -15406.771% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | 48944.639% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | 66797.869% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 69.918% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | 41431.278% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | 932.035% |
| TG Therapeutics, Inc. | 17.86 Million USD | -7630.814% |
| Galecto, Inc. | -21.21 Million USD | 6608.663% |
| Calithera Biosciences, Inc. | -23.78 Million USD | 5905.667% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 12.012% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | 5742.686% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | 12100.33% |
| XBiotech Inc. | -200.02 Million USD | 790.36% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | 1741.928% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | -30396.422% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | 4015.94% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | 1888.285% |
| Theravance Biopharma, Inc. | 5.69 Million USD | -24164.242% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | 910.303% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | 1594.877% |
| Vaxxinity, Inc. | 10.13 Million USD | -13528.879% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | -87.552% |
| Gain Therapeutics, Inc. | -10.76 Million USD | 12924.439% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | 2193.635% |
| NexImmune, Inc. | -3.13 Million USD | 44166.219% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | 40094.462% |
| Marker Therapeutics, Inc. | -15.11 Million USD | 9237.958% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | 5195.491% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | 15484.022% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | 1108571.202% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | 3503.525% |
| Ainos, Inc. | 4.07 Million USD | -33762.246% |
| Pluri Inc. | 22.82 Million USD | -5948.789% |
| Prothena Corporation plc | -608.34 Million USD | 326.989% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | 1262.786% |
| Celularity Inc. | 65.19 Million USD | -2018.236% |
| Rallybio Corporation | -24.1 Million USD | 5829.309% |
| Cue Biopharma, Inc. | -33.81 Million USD | 4183.143% |
| MeiraGTx Holdings plc | -40.3 Million USD | 3526.326% |
| Omeros Corporation | 331.17 Million USD | -316.962% |
| Humacyte, Inc. | -22.48 Million USD | 6241.057% |
| Immunocore Holdings plc | -358.59 Million USD | 485.081% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | 5719.036% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | 4568.716% |
| Blueprint Medicines Corporation | 702.83 Million USD | -96.472% |
| CalciMedica, Inc. | -5.53 Million USD | 25070.669% |
| Cabaletta Bio, Inc. | -188.22 Million USD | 833.651% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | 13619.463% |
| Scholar Rock Holding Corporation | -40.03 Million USD | 3549.005% |
| Sana Biotechnology, Inc. | -33.25 Million USD | 4252.642% |
| Pulmatrix, Inc. | -10.41 Million USD | 13356.005% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | 23203.196% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | 3720.361% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | 1339.545% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | 2403.613% |
| Cytokinetics, Incorporated | 642.37 Million USD | -114.965% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | 23814.202% |
| Nutriband Inc. | -251.65 Thousand USD | 548814.321% |
| Protara Therapeutics, Inc. | -34.11 Million USD | 4147.241% |
| Vor Biopharma Inc. | 4.3 Million USD | -32013.442% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 122.878% |
| Evogene Ltd. | -19.63 Million USD | 7133.096% |
| ProKidney Corp. | -56.23 Million USD | 2555.505% |
| Applied Therapeutics, Inc. | -48.67 Million USD | 2937.11% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | 15049.118% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | -1.245% |
| CorMedix Inc. | -43.05 Million USD | 3307.428% |
| BioLineRx Ltd. | 7.33 Million USD | -18723.31% |
| Tango Therapeutics, Inc. | -27.46 Million USD | 5127.774% |
| Galectin Therapeutics Inc. | 46.14 Million USD | -2892.346% |
| Atai Life Sciences N.V. | -28.55 Million USD | 4935.346% |
| Renovaro Biosciences Inc. | 2.23 Million USD | -61808.094% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | 6152.235% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | -7686.174% |
| Sagimet Biosciences Inc. | -75.07 Million USD | 1939.356% |
| MediciNova, Inc. | -50.78 Million USD | 2819.146% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | 1852.272% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6138699.689% |
| GeoVax Labs, Inc. | -6.45 Million USD | 21500.371% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | 791.057% |
| Biomea Fusion, Inc. | -166.57 Million USD | 929.008% |
| PTC Therapeutics, Inc. | -178.97 Million USD | 871.548% |
| Mereo BioPharma Group plc | -51.46 Million USD | 2782.931% |
| Cullinan Oncology, Inc. | -94.84 Million USD | 1555.947% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 570.072% |
| Absci Corporation | -72.59 Million USD | 2002.088% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -30142.619% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 689.019% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | 1565.729% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | 1542.984% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | 3634.098% |
| Allakos Inc. | -24.97 Million USD | 5629.041% |
| Imunon, Inc. | -4.21 Million USD | 32869.969% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | 9466.965% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | 1119.851% |
| BioAtla, Inc. | -109.01 Million USD | 1366.733% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | -187502.47% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | 147158.36% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | -11440.013% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | 6612.654% |
| XOMA Corporation | -29 Million USD | 4861.648% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | 8438.635% |
| Cara Therapeutics, Inc. | -9.01 Million USD | 15415.861% |
| aTyr Pharma, Inc. | -7.44 Million USD | 18637.763% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | 1207.929% |
| Akero Therapeutics, Inc. | -208.16 Million USD | 763.361% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | 1788.548% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | 1588.609% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | 160819.706% |
| Akari Therapeutics, Plc | -3.84 Million USD | 36013.602% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -84987.591% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 116322.315% |
| UroGen Pharma Ltd. | 4.39 Million USD | -31347.916% |
| Sutro Biopharma, Inc. | 113.48 Million USD | -1116.836% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | -1918798.863% |
| Orgenesis Inc. | 21.78 Million USD | -6238.955% |
| Entera Bio Ltd. | -10.62 Million USD | 13091.608% |
| GH Research PLC | -78.07 Million USD | 1868.61% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | 6295.612% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | 5279.782% |
| Xencor, Inc. | 29.64 Million USD | -4558.204% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | 70202.02% |
| Replimune Group, Inc. | 1.41 Million USD | -97695.892% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | 563935.399% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | 1192.32% |
| Lexaria Bioscience Corp. | -1.18 Million USD | 116322.315% |
| Portage Biotech Inc. | -4.98 Million USD | 27822.907% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | 6138699.689% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | 2188.379% |
| OncoCyte Corporation | -6.56 Million USD | 21140.347% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | -153773.189% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | 30411.374% |
| Purple Biotech Ltd. | -14.13 Million USD | 9867.138% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | 5912.755% |
| scPharmaceuticals Inc. | -6.54 Million USD | 21198.212% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | 8372.612% |
| HilleVax, Inc. | -165.48 Million USD | 934.443% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | 54508.117% |
| Tharimmune, Inc. | -10.93 Million USD | 12727.65% |
| Genprex, Inc. | -6.73 Million USD | 20595.014% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 474.418% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | 1661.02% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | 98663.74% |
| Virios Therapeutics, Inc. | -3.31 Million USD | 41731.006% |
| OKYO Pharma Limited | -826.84 Thousand USD | 167105.06% |
| Savara Inc. | 153 Thousand USD | -902434.641% |
| Curis, Inc. | -23.88 Million USD | 5880.877% |
| Daré Bioscience, Inc. | -5.15 Million USD | 26872.04% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | 178045.444% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | 22343.524% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | -116429.789% |
| BeiGene, Ltd. | -2.25 Billion USD | 161.288% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | -11091.62% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 327.042% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | 844.064% |
| Erasca, Inc. | -37.21 Million USD | 3810.442% |
| bluebird bio, Inc. | 108.57 Million USD | -1171.866% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 107319.932% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | -264.59% |
| DBV Technologies S.A. | -126.98 Million USD | 1187.425% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | 107319.932% |
| Moderna, Inc. | -2.9 Billion USD | 147.502% |
| Vincerx Pharma, Inc. | -10.35 Million USD | 13439.239% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | 12805.907% |
| Molecular Templates, Inc. | 707 Thousand USD | -195215.134% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | 4501.766% |
| Travere Therapeutics, Inc. | 346.6 Million USD | -298.398% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | 1782.725% |
| Spruce Biosciences, Inc. | -91.73 Million USD | 1605.372% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | 4378.873% |
| Cogent Biosciences, Inc. | -34.37 Million USD | 4116.983% |
| MacroGenics, Inc. | -66.98 Million USD | 2161.473% |
| RenovoRx, Inc. | -1.17 Million USD | 117821.91% |
| Adicet Bio, Inc. | -138.78 Million USD | 1094.962% |
| Prime Medicine, Inc. | -27.94 Million USD | 5042.121% |
| Aditxt, Inc. | 18.12 Million USD | -7520.367% |
| Adagene Inc. | -87.62 Million USD | 1675.852% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 33250.927% |
| Quantum-Si incorporated | -118.55 Million USD | 1264.738% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | -3735.24% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | 18575.291% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | 2946.643% |
| SciSparc Ltd. | -2.06 Million USD | 66970.605% |
| Vericel Corporation | 1.27 Million USD | -108034.534% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 11615.28% |
| Minerva Neurosciences, Inc. | 41 Million USD | -3267.646% |
| Generation Bio Co. | 31.44 Million USD | -4290.988% |
| Astria Therapeutics, Inc. | -175.36 Million USD | 887.435% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | 4565.537% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | -1084.358% |
| Invivyd, Inc. | -198.47 Million USD | 795.741% |
| Relay Therapeutics, Inc. | -90.27 Million USD | 1629.72% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | 57692.057% |
| Spero Therapeutics, Inc. | -70.79 Million USD | 2050.668% |
| Artelo Biosciences, Inc. | -6.82 Million USD | 20332.645% |
| 2seventy bio, Inc. | 181.71 Million USD | -659.914% |
| ADMA Biologics, Inc. | 90.06 Million USD | -1433.185% |
| Clene Inc. | 3.34 Million USD | -41243.653% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | 15303.382% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | 6519.404% |
| GeoVax Labs, Inc. | -6.45 Million USD | 21500.371% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 501.273% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | 5411.134% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | -677.233% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | 33849.368% |
| Finch Therapeutics Group, Inc. | 5 Million USD | -27506.517% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | 26609.464% |
| Vir Biotechnology, Inc. | -130.3 Million USD | 1159.736% |
| Evaxion Biotech A/S | 5.28 Million USD | -26019.136% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | 1326.706% |
| Verve Therapeutics, Inc. | -131.27 Million USD | 1151.913% |
| Trevena, Inc. | 2.25 Million USD | -61054.916% |
| Surrozen, Inc. | -32.66 Million USD | 4327.523% |
| Tyra Biosciences, Inc. | -51.51 Million USD | 2780.796% |
| Cingulate Inc. | 3.08 Million USD | -44694.68% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | 47116.616% |
| Unity Biotechnology, Inc. | 7.18 Million USD | -19113.552% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | 14962.171% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | 1840.829% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | 1150.481% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | 1408.368% |
| Clearmind Medicine Inc. | -3.94 Million USD | 35124.224% |
| Kronos Bio, Inc. | -36.05 Million USD | 3930.027% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | -14576.14% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -94602.176% |
| Viking Therapeutics, Inc. | -54.25 Million USD | 2645.116% |
| Statera Biopharma, Inc. | 14.41 Million USD | -9478.518% |
| ImmunityBio, Inc. | 618.22 Million USD | -123.362% |
| Korro Bio, Inc. | -132.94 Million USD | 1138.699% |
| Kineta, Inc. | -4.54 Million USD | 30509.117% |
| BioVie Inc. | -17.73 Million USD | 7887.337% |
| Codexis, Inc. | -43.27 Million USD | 3291.232% |
| Celularity Inc. | 65.19 Million USD | -2018.236% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | 43674.566% |
| Celcuity Inc. | 6.78 Million USD | -20256.397% |
| Virax Biolabs Group Limited | -3.36 Million USD | 41137.176% |
| Cibus, Inc. | -8.07 Million USD | 17194.306% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | 32752.589% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | -30116.149% |
| IN8bio, Inc. | -16.38 Million USD | 8525.639% |
| Kodiak Sciences Inc. | -103.87 Million USD | 1429.365% |
| Annexon, Inc. | -193.75 Million USD | 812.693% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | -3835672.222% |
| Assembly Biosciences, Inc. | -17.49 Million USD | 7991.182% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | 39407.657% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | -30.979% |
| Eyenovia, Inc. | 1.25 Million USD | -109606.507% |
| Puma Biotechnology, Inc. | 26.9 Million USD | -5032.421% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 42680.265% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | 4253.391% |
| Arcellx, Inc. | -296.95 Million USD | 565.008% |
| Cardiff Oncology, Inc. | -19.5 Million USD | 7179.247% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | 2445.44% |
| Regulus Therapeutics Inc. | -20.72 Million USD | 6762.218% |
| Moolec Science SA | 117.61 Thousand USD | -1173956.251% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | 3696.13% |
| Geron Corporation | 14.76 Million USD | -9254.908% |
| LAVA Therapeutics N.V. | -37.91 Million USD | 3741.748% |
| Royalty Pharma plc | 5.65 Billion USD | 75.595% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | 1076.431% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | 19856.678% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | 25848.915% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | 1081.218% |
| Humacyte, Inc. | -22.48 Million USD | 6241.057% |
| Structure Therapeutics Inc. | -124.33 Million USD | 1210.575% |
| 89bio, Inc. | -289.05 Million USD | 577.725% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | 5570.557% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | 77546.887% |
| Genelux Corporation | -6.89 Million USD | 20115.625% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | 4545.983% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | -1551.788% |
| Notable Labs, Ltd. | -9.77 Million USD | 14225.184% |
| Liquidia Corporation | -80.17 Million USD | 1822.308% |
| Mustang Bio, Inc. | -3.73 Million USD | 37061.403% |
| Immunovant, Inc. | -635.22 Million USD | 317.383% |
| Quantum-Si incorporated | -118.55 Million USD | 1264.738% |
| Arbutus Biopharma Corporation | -17.56 Million USD | 7961.979% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | 33430.389% |
| Vera Therapeutics, Inc. | 8.02 Million USD | -17102.915% |
| Acasti Pharma Inc. | -23 Million USD | 6102.512% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | 41109.328% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | 8598.039% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | 1102.525% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | 44410.578% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | 6311.218% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | 7536.469% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | 915.746% |
| PepGen Inc. | -60.67 Million USD | 2376.047% |
| Moleculin Biotech, Inc. | -22.97 Million USD | 6110.089% |
| United Therapeutics Corporation | -507.7 Million USD | 371.987% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | 7319.9% |
| Solid Biosciences Inc. | -47.75 Million USD | 2991.891% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | 160278.125% |
| Immuneering Corporation | -54.94 Million USD | 2613.298% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | 32950.766% |
| Silo Pharma, Inc. | -3.52 Million USD | 39281.536% |
| Belite Bio, Inc | -87.27 Million USD | 1682.287% |
| XOMA Corporation | -29 Million USD | 4861.648% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | 2053.234% |
| Bionomics Limited | 227 Million USD | -508.29% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | 1287.525% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 54615.515% |
| uniQure N.V. | -102.95 Million USD | 1441.296% |
| Cassava Sciences, Inc. | -121.13 Million USD | 1239.94% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | 33250.927% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | -3272.025% |
| Forte Biosciences, Inc. | -11.96 Million USD | 11644.837% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | 44727.949% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | -1302615.094% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | 42680.265% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | -15406.771% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | 18720.254% |
| Altimmune, Inc. | -134.48 Million USD | 1126.774% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | -597.184% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | 54615.515% |
| Compugen Ltd. | -12.9 Million USD | 10801.162% |
| Peak Bio, Inc. | 10.34 Million USD | -13254.515% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | 488042.756% |
| Benitec Biopharma Inc. | -50.58 Million USD | 2829.979% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | 1423.466% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | -6929.158% |
| Zura Bio Limited | -99.8 Million USD | 1483.562% |
| PolyPid Ltd. | 6.17 Million USD | -22280.519% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | -1763.03% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | -6929.158% |
| Instil Bio, Inc. | 75.35 Million USD | -1732.424% |
| argenx SE | -2.02 Billion USD | 168.062% |
| Immunome, Inc. | -97.02 Million USD | 1523.16% |
| Compass Therapeutics, Inc. | -22.49 Million USD | 6238.6% |
| Verona Pharma plc | -220.44 Million USD | 726.41% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | 2024.756% |
| Shattuck Labs, Inc. | -121.42 Million USD | 1237.236% |
| CervoMed Inc. | -7.79 Million USD | 17819.816% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | 844.413% |
| Plus Therapeutics, Inc. | -4.37 Million USD | 31677.361% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | 1148.184% |
| Moolec Science SA | 117.61 Thousand USD | -1173956.251% |
| Enveric Biosciences, Inc. | -2.28 Million USD | 60453.666% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | -8585.652% |
| AnaptysBio, Inc. | -18.15 Million USD | 7707.724% |
| Design Therapeutics, Inc. | -18.15 Million USD | 7708.143% |
| Leap Therapeutics, Inc. | -70.38 Million USD | 2062.004% |
| NeurAxis, Inc. | 145.7 Thousand USD | -947654.29% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | -12194.142% |
| Lumos Pharma, Inc. | -28.49 Million USD | 4946.376% |
| Achilles Therapeutics plc | -126.92 Million USD | 1187.957% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | 2024.756% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | 210686.369% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | 6747.201% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | -94602.176% |
| Nutriband Inc. | -251.65 Thousand USD | 548814.321% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | 10584.231% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | 18660.188% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | -305.905% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | -5717.898% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 408.596% |
| Palisade Bio, Inc. | -12.06 Million USD | 11547.219% |
| Tourmaline Bio, Inc. | -140.31 Million USD | 1084.155% |
| Beam Therapeutics Inc. | -262.72 Million USD | 625.604% |
| Neurogene Inc. | -131.95 Million USD | 1146.476% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | -6229.657% |
| AEON Biopharma, Inc. | -4.88 Million USD | 28396.68% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 466.095% |
| Sesen Bio, Inc. | -112.55 Million USD | 1326.869% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | 1482.814% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | 58916.003% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | 3638.354% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | 1758.075% |
| Athira Pharma, Inc. | -88.99 Million USD | 1651.566% |
| Vaccinex, Inc. | -1.28 Million USD | 107311.025% |
| HCW Biologics Inc. | 2.85 Million USD | -48238.629% |
| XOMA Corporation | -29 Million USD | 4861.648% |
| Nektar Therapeutics | 210.24 Million USD | -556.81% |
| Arvinas, Inc. | -313.8 Million USD | 540.05% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | -84987.591% |
| Merus N.V. | -192.88 Million USD | 815.911% |
| Omega Therapeutics, Inc. | 59.98 Million USD | -2202.039% |
| Quince Therapeutics, Inc. | -6.93 Million USD | 20003.113% |
| Rezolute, Inc. | -68.16 Million USD | 2125.698% |
| Clene Inc. | 3.34 Million USD | -41243.653% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | 10571.51% |
| BeyondSpring Inc. | -13.75 Million USD | 10139.099% |
| Synlogic, Inc. | -6.68 Million USD | 20756.365% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | -121670.547% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | 16432.088% |
| Peak Bio, Inc. | 10.34 Million USD | -13254.515% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | 1775.416% |
| Krystal Biotech, Inc. | -350.23 Million USD | 494.273% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | -1012.49% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | 917.107% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | 43838.201% |
| MannKind Corporation | 143.89 Million USD | -859.616% |
| Ikena Oncology, Inc. | -109.15 Million USD | 1365.05% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | 18339.044% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | 4271.837% |
| Gossamer Bio, Inc. | 180.35 Million USD | -665.644% |
| CohBar, Inc. | -5.93 Million USD | 23383.437% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | 4741.919% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | -30142.619% |
| Legend Biotech Corporation | -949.39 Million USD | 245.448% |
| Mural Oncology plc | -255.84 Million USD | 639.736% |
| Biora Therapeutics, Inc. | 32.21 Million USD | -4186.444% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | 29414.009% |
| Disc Medicine, Inc. | -358.28 Million USD | 485.418% |
| Champions Oncology, Inc. | 4.81 Million USD | -28596.55% |
| REGENXBIO Inc. | 54.76 Million USD | -2421.323% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | 513615.081% |
| Anavex Life Sciences Corp. | -151.02 Million USD | 1014.343% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | 15422.648% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | 1811.486% |
| Vaxart, Inc. | -8.24 Million USD | 16856.195% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | 2851.851% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | 1185.889% |
| Cellectis S.A. | -43.85 Million USD | 3248.736% |
| Longeveron Inc. | -2.9 Million USD | 47585.488% |
| Repare Therapeutics Inc. | -107.85 Million USD | 1380.274% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | -42.597% |
| Inozyme Pharma, Inc. | 12 Million USD | -11403.482% |
| Revolution Medicines, Inc. | -608.2 Million USD | 327.042% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | 112366.504% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 620.856% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | 1020.144% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | 8925.193% |
| Anixa Biosciences, Inc. | -740 Thousand USD | 186705.135% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 114.438% |
| Denali Therapeutics Inc. | -74.86 Million USD | 1944.491% |
| Revelation Biosciences, Inc. | -11.99 Million USD | 11615.28% |
| Veru Inc. | 4.77 Million USD | -28788.848% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | 12378.837% |
| Cingulate Inc. | 3.08 Million USD | -44694.68% |
| Passage Bio, Inc. | 4.58 Million USD | -30017.296% |
| Context Therapeutics Inc. | -14.44 Million USD | 9656.364% |
| Exicure, Inc. | 5.84 Million USD | -23508.788% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 699.402% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | 3589.709% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | -8700.446% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | 2447.594% |
| Nuvalent, Inc. | -335.38 Million USD | 511.727% |
| ABVC BioPharma, Inc. | 1.73 Million USD | -79519.752% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | 1953.975% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | 15632.936% |
| OmniAb, Inc. | 9.2 Million USD | -14904.651% |
| Anew Medical, Inc. | 1.43 Million USD | -96298.725% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | -8329.365% |
| Lipocine Inc. | -4.75 Million USD | 29143.039% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | 1357.31% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | -8966.233% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | 2825.829% |
| G1 Therapeutics, Inc. | 24.89 Million USD | -5447.477% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | 20645.722% |
| Sage Therapeutics, Inc. | -65.82 Million USD | 2197.738% |
| Ocugen, Inc. | -32.52 Million USD | 4346.112% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | 1713.647% |
| Q32 Bio Inc. | -37.94 Million USD | 3738.869% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | 219985.032% |
| Alumis Inc. Common Stock | -13.52 Million USD | 10306.8% |
| Equillium, Inc. | -22.39 Million USD | 6266.836% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | 5500.806% |
| Coya Therapeutics, Inc. | -32.62 Million USD | 4332.347% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | 557096.551% |
| Galera Therapeutics, Inc. | 134.04 Million USD | -930.183% |
| Evelo Biosciences, Inc. | 3.19 Million USD | -43079.425% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | -420334.111% |
| Dominari Holdings Inc. | 195 Thousand USD | -708042.564% |
| Edesa Biotech, Inc. | -5.26 Million USD | 26317.991% |
| vTv Therapeutics Inc. | -8.91 Million USD | 15585.903% |
| Bio-Techne Corporation | 267.74 Million USD | -415.74% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | 8619.205% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | 1269.304% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | 16533.155% |
| Candel Therapeutics, Inc. | -12.65 Million USD | 11015.169% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 663.35% |
| Nkarta, Inc. | 57.29 Million USD | -2309.951% |
| BioCardia, Inc. | 212 Thousand USD | -651257.547% |
| Iterum Therapeutics plc | 13.43 Million USD | -10175.919% |